RecruitingN/Aketamine

Anesthesia Techniques, Neuroprotection and Surgical Field in FESS Under Controlled Hypotension

Sponsored by University General Hospital of Patras

NCT ID
NCT07181564
Target Enrollment
150 participants
Start Date
2025-09-11
Est. Completion
2026-03-20

About This Study

This prospective, randomized controlled trial investigates the effect of four different anesthetic maintenance techniques on surgical field conditions, hemodynamic stability, and neuroprotection during functional endoscopic sinus surgery (FESS) performed under controlled hypotension. Patients are randomly assigned to receive either total intravenous anesthesia with propofol-remifentanil, propofol-remifentanil with adjunct ketamine and magnesium, sevoflurane-remifentanil, or sevoflurane-remifentanil with adjunct ketamine and magnesium. Primary outcomes include serum biomarkers of neuronal injury (S100B and neuron-specific enolase, NSE) measured perioperatively, as well as surgical field visibility and intraoperative bleeding scores. Secondary outcomes include recovery profile and postoperative pain.

Conditions Studied

Magnesium SulfateRemifentanilS 100betaS100 Beta Protein, HumanNeuron-Specific EnolaseBrain IschemiaSevoflurane AnaesthesiaPropofol/RemifentanilKetamine

Interventions

  • Propofol / Remifentanil
  • Ketamine + Magnesium sulfate (drug combination)
  • Sevoflurane and Remifentanil

Eligibility

Age:18 Years - 90 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria :

Adult patients (≥18 years old). Scheduled for F.E.S.S (Functional endoscopic sinus surgery ) under general anesthesia.

Able to provide informed consent

Exclusion Criteria:

Emergency surgery. ASA physical status IV-V. Severe hepatic or renal dysfunction. Known allergy or contraindication to study drugs. Pregnant or lactating women. unable to provide informed consent

Patients unwilling or unable to provide consent.

Study Locations (1)

University General Hospital of Patras
Pátrai, Achaia, Greece

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

Sotiria Rizopoulou, M.D.,M.Sc.
CONTACT
+306949454352rizsotiria@gmail.com
View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source